2019年冠状病毒病大流行对澳大利亚新南威尔士州原发性皮肤黑色素瘤诊断和管理的影响：一项回顾性队列研究
Impact of the COVID-19 pandemic on the diagnosis and management of primary cutaneous melanomas in New South Wales, Australia: A retrospective cohort study.
作者信息
Thomas Meryl, Jones-Caballero Maria, Wijaya Marlene, Fernandez-Penas Pablo, Ruiz Araujo Raquel
机构信息
MBBS, Dermatology Clinical Trials Sub-Investigator and Research Fellow, Sinclair DIRECT, Dermatology Investigational Research, Education and Clinical Trials Centre, Melbourne, Vic; Patient Teaching Associate Program Facilitator, Monash School of Medicine, Monash University, Melbourne, Vic.
MD, FACD, PhD, Consultant Dermatologist, Department of Dermatology, Westmead Hospital, Sydney, NSW; Clinical Senior Lecturer, Sydney Medical School, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW.
出版信息
Aust J Gen Pract. 2024 Dec-Supplement;53(12 Suppl):S71-S77. doi: 10.31128/AJGP-10-23-6991.
BACKGROUND AND OBJECTIVES
The COVID-19 pandemic caused upheaval of healthcare systems, with evolving consequences. The aim of this study was to evaluate the impact of the pandemic on melanoma diagnosis and management in New South Wales, Australia.
METHOD
In this retrospective cohort study, we analysed all new melanomas diagnosed at a tertiary care hospital over a three-year period. We compared outcomes between pre-pandemic (1 January 2019 - 30 March 2020) and pandemic (31 March 2020 - 31 December 2021) periods.
RESULTS
A total of 426 melanomas were included. No significant differences in patient demographics, Breslow thickness, ulceration, subtype or lymph node positivity were observed. During the pandemic, there was an 11% decrease in the number of melanomas diagnosed in the community (P=0.016) and an 11-day reduction in time from referral to wide local excision (P=0.013).
DISCUSSION
The prioritisation of melanoma care during the pandemic in New South Wales, Australia, has resulted in no apparent diagnostic delays.
背景与目的
新冠疫情导致医疗系统动荡，影响不断演变。本研究旨在评估疫情对澳大利亚新南威尔士州黑色素瘤诊断与治疗的影响。
方法
在这项回顾性队列研究中，我们分析了一家三级护理医院在三年期间诊断出的所有新发黑色素瘤病例。我们比较了疫情前（2019年1月1日至2020年3月30日）和疫情期间（2020年3月31日至2021年12月31日）的结果。
结果
共纳入426例黑色素瘤病例。在患者人口统计学、 Breslow厚度、溃疡情况、亚型或淋巴结阳性方面未观察到显著差异。在疫情期间，社区诊断出的黑色素瘤数量减少了11%（P = 0.016），从转诊到广泛局部切除的时间缩短了11天（P = 0.013）。
讨论
在澳大利亚新南威尔士州，疫情期间黑色素瘤护理的优先安排并未导致明显的诊断延迟。
Zotero 插件